Published by Michele Maatouk on 20th April 2022
(Sharecast News) - Hikma Pharmaceuticals has received preliminary approval from the US Federal Trade Commission for the acquisition of sterile injectables company Custopharm Inc from Water Street Healthcare for up to $425m.
URL: http://www.digitallook.com/dl/news/story/32615579/...